LXR beta agonists (Merck Research Laboratories/WuXi PharmaTech)

N/A

Report date: 2025/01/26 18:37:22
NME

Base Information

Drug NameLXR beta agonists (Merck Research Laboratories/WuXi PharmaTech)
Drug Alias NameLXR agonists (Merck)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOxysterols receptor LXR-beta agonists
TargetsOxysterols receptor LXR-beta
Therapy Area/IndicationsAtherosclerosisAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesMerck Research Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesMerck Research LaboratoriesWuxi Apptec Co Ltd
Inactive CompaniesN/A
Active IndicationsAtherosclerosisAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A